ORBIMED ADVISORS LLC: 13F holdings
CIK 10559512026Q2
| Positions | 123 |
|---|
| Reported value | $5.4bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 123 (+13 vs prior quarter) |
|---|
| Reported value | $5.4bn (+7.0%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| EWTX EDGEWISE THERAPEUTICS INC | 15,518,492 | $630.5m | 11.7% |
| ELVN ENLIVEN THERAPEUTICS INC | 6,776,632 | $343.9m | 6.4% |
| LLY ELI LILLY & CO | 257,900 | $309.3m | 5.7% |
| MBX MBX BIOSCIENCES INC | 3,428,736 | $189.3m | 3.5% |
| SINOVAC BIOTECH LTD | 2,718,735 | $184.5m | 3.4% |
| ASTRAZENECA PLC | 915,700 | $171.1m | 3.2% |
| GPCR STRUCTURE THERAPEUTICS INC | 2,209,400 | $118.6m | 2.2% |
| SION SIONNA THERAPEUTICS INC | 2,555,877 | $112.4m | 2.1% |
| CRVS CORVUS PHARMACEUTICALS INC | 7,165,006 | $107.0m | 2.0% |
| AVBP ARRIVENT BIOPHARMA INC | 3,027,328 | $105.2m | 1.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1055951")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples